These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8881581)

  • 21. [Treatment of hepatocellular carcinoma with tamoxifen].
    Paliard P; Clément G; Saez S; Chabal J; Partensky C
    Gastroenterol Clin Biol; 1984; 8(8-9):680-1. PubMed ID: 6092188
    [No Abstract]   [Full Text] [Related]  

  • 22. Megestrol treatment in patients with hepatocellular carcinoma.
    Farinati F; Gianni S; De Giorgio M; Fiorentini S
    Br J Cancer; 2001 Nov; 85(10):1606-8. PubMed ID: 11720452
    [No Abstract]   [Full Text] [Related]  

  • 23. Octreotide and hepatocellular carcinoma.
    Farinati F; Sergio A; Baldan A; Zucchetta P; Corleto VD
    Br J Cancer; 2007 Jun; 96(11):1778-9. PubMed ID: 17505506
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of large hepatocellular carcinoma.
    Amarapurkar DN
    J Assoc Physicians India; 2004 Apr; 52():319-21. PubMed ID: 15636337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Randomized trial of elliptinium acetate and tamoxifen in the treatment of inoperable hepatocellular carcinoma].
    Jouanolle H; Delamaire D; Deugnier Y; Lhéry D; Simon M; Brissot P; Bourel M
    Gastroenterol Clin Biol; 1986 Feb; 10(2):185-7. PubMed ID: 3009255
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
    Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL
    Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy and medical treatment of hepatocellular carcinoma (HCC).
    Rougier P; Mitry E; Clavero-Fabri MC
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1264-6. PubMed ID: 9730386
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic treatment of hepatocellular carcinoma.
    Treiber G
    Dig Dis; 2001; 19(4):311-23. PubMed ID: 11935091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific review of tamoxifen. Overview from a medical oncologist.
    Carlson RW
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-151-S1-7. PubMed ID: 9045312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
    Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope?
    Cipriani G; Mazzanti R
    Dig Liver Dis; 2005 Apr; 37(4):230-1. PubMed ID: 15788205
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors.
    Villa E; Ferretti I; Grottola A; Buttafoco P; Buono MG; Giannini F; Manno M; Bertani H; Dugani A; Manenti F
    Br J Cancer; 2001 Apr; 84(7):881-5. PubMed ID: 11286465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.
    Borbath I; Horsmans Y
    Hepatology; 2003 Feb; 37(2):477-8; author reply 478. PubMed ID: 12575712
    [No Abstract]   [Full Text] [Related]  

  • 34. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
    Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L;
    Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local/regional and systemic treatments of hepatocellular carcinoma.
    Beaugrand M; N'kontchou G; Seror O; Ganne N; Trinchet JC
    Semin Liver Dis; 2005; 25(2):201-11. PubMed ID: 15918148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of a tamoxifen-norethisterone combination in 16 patients with hepatocellular carcinoma].
    Trinchet JC; Roudil F; Vaysse J; Beaugrand M
    Gastroenterol Clin Biol; 1985 May; 9(5):455-6. PubMed ID: 2989070
    [No Abstract]   [Full Text] [Related]  

  • 37. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells.
    Lin HL; Liu TY; Lui WY; Chi CW
    Cancer; 1999 May; 85(9):1937-42. PubMed ID: 10223233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
    Chow PK; Tai BC; Tan CK; Machin D; Win KM; Johnson PJ; Soo KC;
    Hepatology; 2002 Nov; 36(5):1221-6. PubMed ID: 12395333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.
    Nowak AK; Stockler MR; Chow PK; Findlay M
    Cancer; 2005 Apr; 103(7):1408-14. PubMed ID: 15744746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
    Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.